|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | ACR appropriateness criteria:local excision in early-stage rectal cancer显示文摘 | Blackstock W Russo SM Suh WW | 2010 | Curr Probl Cancer2010，34，3： | 1 |
| 2 | Epidermal growth fac- tor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5- fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I study 显示文摘 | Dobelbower MC Russo SM Raisch KP | 2006 | Anticancer Drugs2006，17，1： | 1 |
| 3 | Enhancement of radiosensitivity by proteasome inhibition:implications for a role of NF-kappaB显示文摘 | Russo SM Tepper JE Baldwin AS Jr | 2001 | Int J Radiat Oncol Biol Phys2001，50，1： | 1 |
| 4 | Stretching and electrical stimulation reduce the accumulation of Myo D,myostatin and atrogin-1 in denervated rat skeletal muscle显示文摘 | Russo TL Peviani SM Durigan JL | 2010 | J Muscle Res Cell Motil2010，31，1： | 1 |
| 5 | Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NFkappaB显示文摘 | Russo SM Tepper JE Baldwin AS Jr | 2001 | Int J Radiat Oncol Biol Phys2001，50，1： | 1 |
| 6 | Enhancement of radiosensitivity by proteasome inhibition:implications for a role of NFкB显示文摘 | Russo SM Tepper JE Baldwin AS Jr | 2001 | Int J Radiat Oncol Biol Phys2001，50，1： | 1 |
| 7 | Epidermal growth factor receptor tyrosine kinase inhibitor,erlotinib,and concurrent 5-fluorouracil,cisplatin and radiotherapy for patients with esophageal cancer:a phase Ⅰ study显示文摘 | Dobelbower MC Russo SM Raisch KP | 2006 | Anticancer Drugs2006，17，1： | 1 |
| 8 | Anti-EGFR-mediated radiosensitization as a result of augmented EGFR exDression显示文摘 | Bonner JA Buchsbaum DJ Russo SM | | 0，，： | 1 |
| 9 | Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR显示文摘 | Russo AM Wang Y A1-Khatib SM | 2013 | Pacing Clin Electrophysiol2013，36，12： | 1 |
| 10 | Gynecologic and Surgical Complications in Type 1V Ehlers-Danlos Syndrome 显示文摘 | Wheeler SM Russo M Wilson-Murphy M | 2014 | Obstet Gynecol2014，123，222： | 1 |
| 11 | Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I study显示文摘 | Dobelbower MC Russo SM Raisch KP | 2006 | Anticancer Drugs2006，17，1： | 1 |
| 12 | Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB显示文摘 | Russo SM Tepper JE Baldwin AS Jr | 2001 | Int J Radiat Oncol Biol Phys2001，50，1： | 1 |
| 13 | Traumatic brain injury in the elderly increased mortalityand worse functional outcome at discharge despite lower injury severity显示文摘 | Susman MD Russo SM Sullivan T | 2002 | Trauma2002，53，2： | 1 |
| 14 | Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5 - fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase Ⅰ study显示文摘 | Dobelbower MC Russo SM Raisch KP | 2006 | Anticancer Drugs2006，17，1： | 1 |
| 15 | Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase Ⅰ study显示文摘 | Dobelbower MC Russo SM Raisch KP | 2006 | Anticancer Drugs2006，17，1： | 1 |
| 16 | Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5 - fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I study 显示文摘 | DOBELBOWER MC RUSSO SM RAISCH KP | 2006 | Anticancer Drugs2006，17，1： | 1 |
| 17 | The muhidiscipli- nary approach to the treatment of rectal cancer:2015 update 显示文摘 | Onyeuku NE Ayala-Peacock DN Russo SM | 2015 | Ex- pert Rev Gastroenterol Hepatol2015，9，4： | 1 |
| 18 | Enhancement of radiosensitivity by proteasome inhibition:implications for a role of NF-κB显示文摘 | Russo SM Tepper JE Baldwin AS Jr | | 0，，1： | 1 |
| 19 | Epidermal growth factor receptor tyrosine kinase inhibitor,erlotinib,and concurrent 5-fluorouracil,cisplatin and radiotherapy for patients with esophageal cancer:a phase I study显示文摘 | Dobelbower MC Russo SM Raisch KP | 2006 | Anticancer Drugs2006，17，1： | 1 |
| 20 | Epidermal growth factor receptor tyrosine kinase inhibitor,erlotinib,and concurrent 5-fluorouracil,cisplatin and radiotherapy for patients with esophageal cancer:a phase I study显示文摘 | Dobelbower MC Russo SM Raisch KP | 2006 | Anti-Cancer DrugS2006，17，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员